Use of glucarpidase (carboxypeptidase‐G2) in pediatric cancer patients: 11‐year experience of a tertiary center by Rocío Vila, Alba Rubio‐San‐Simón, Pablo Zubiaur, Marcos Navares‐Gómez, Patricia Gómez‐Hernández, Begoña Arce, Luis Madero

Get full text

Congenital transmission of Chagas disease in a non-endemic area, is an early diagnosis possible? by Laura Francisco-González, Alba Rubio-San-Simón, María Isabel González-Tomé, Ángela Manzanares, Cristina Epalza, María Del Mar Santos, Teresa Gastañaga, Paloma Merino, José Tomás Ramos-Amador

Get full text

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial by Jaume Mora, Godfrey C. F. Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Jörg Faber, Arthur Wingerter, Melissa K. Bear, Alba Rubio-San-Simon, Blanca Martínez de Las Heras, Karen Tornøe, Maria Düring, Brian H. Kushner

Get full text

Safety and outcome of children, adolescents and young adults participating in phase I/II clinical oncology trials: a 9-year center experience by Anna Pujol Manresa, Anna Pujol Manresa, Susana Buendía López, Maitane Andión, Maitane Andión, Blanca Herrero, Blanca Herrero, Álvaro Lassaletta, Manuel Ramirez, Manuel Ramirez, David Ruano, David Ruano, Carmen Hernández-Marqués, Amalia Varo, Teresa de Rojas, Marta Cortés Hernández, Jaime Verdú-Amorós, Jaime Verdú-Amorós, Jaime Verdú-Amorós, Silvia Martín Prado, Andrea Artigas, Esther Redondo, Julia Ruiz Pato, Pilar Herreros López, Julián Sevilla, Luis Madero, Luis Madero, Lucas Moreno, Francisco Bautista Sirvent, Francisco Bautista Sirvent, Alba Rubio-San-Simón, Alba Rubio-San-Simón

Get full text

Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial by Edoardo Pennesi, Erica Brivio, Anneke C. J. Ammerlaan, Yilin Jiang, Vincent H. J. van der Velden, H. Berna Beverloo, Barbara Sleight, Franco Locatelli, Benoit Brethon, Claudia Rossig, Gernot Engstler, Anna Nilsson, Benedicte Bruno, Arnaud Petit, Bella Bielorai, Carmelo Rizzari, Fanny Rialland, Alba Rubio-San-Simón, Francisco J. Bautista Sirvent, Cristina Diaz-de-Heredia, Susana Rives, Christian M. Zwaan

Get full text

Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations by Beatriz Martín-Antonio, Belén Blanco, África González-Murillo, Laura Hidalgo, Jordi Minguillón, Gema Pérez-Chacón, Next Generation CART MAD Consortium, Jordi Minguillón, Lucía Fernández, Halin Bareke, Andrés París-Muñoz, Adriana Mañas, Cristina Aguirre-Portolés, Alfonso Navarro-Zapata, Carmen Mestre-Durán, Marta Ibáñez-Navarro, Laura Clares-Villa, Sara Naharro, Antonio Perez-Martinez, Marcos Aldea, María Gaibar, Javier Ruiz-Navarro, Manuel Izquierdo, Juan M. Zapata, África González Murillo, Elena García Sánchez, Jorge García Martínez, Alba Rubio San Simón, Blanca Herrero, Gonzalo García Aguilera, Beatriz Horcajo Morera, Manuel Ramírez Orellana, Belén Blanco-Durango, Anais Jiménez-Reinoso, Rodrigo Lázaro-Gorines, Ivana Zagorac, Antonio Tapia Galisteo, Ángel Ramirez-Fernández, Laura Díez-Alonso, Carmen Dominguez-Alonso, Ainhoa Erce-Llamazares, Oana Hangiu, Laura Rubio Pérez, Marina Gómez Rosel, Alejandro Segura Tudela, Javier Arroyo-Ródena, Luis Álvarez-Vallina, Miguel Ángel Rodríguez Milla, Patricia García Rodríguez, Beatriz Somovilla Crespo, Javier García-Castro, Esperanza Esquinas Tarifa, Juana Serrano-López, Pilar Llamas-Sillero, Beatriz Martin-Antonio

Get full text